Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ADEL Y01

Next Previous
X
Search
Drug Profile

ADEL Y01

Alternative Names: ADEL-Y01

Latest Information Update: 27 Feb 2024

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator ADEL
  • Developer ADEL; Oscotec
  • Class Antidementias; Monoclonal antibodies
  • Mechanism of Action Tau protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Phase I Alzheimer's disease

Most Recent Events

  • 27 Feb 2024 CTP push - 367368: Trial info covered; updated the previously added trial info from pipeline with NCT info; KDM, devT updated; previous HE corrected; no qual added as trial includes both patients and volunteers
  • 30 Jan 2024 Phase-I clinical trials in Alzheimer's disease in USA (IV) (NCT06247345)
  • 18 Sep 2023 ADEL Y01 is available for licensing as of 18 Sep 2023. https://www.adelpharm.com/adel-ynn

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top